Home
About Us
Background
Investment Strategy
Team
Portfolio
News
Contact
中文
Investor Login
Home
About Us
Background
Investment Strategy
Team
Portfolio
News
Contact
中文
Investor Login
We are Company Builders
Identifying, incubating and growing future industry leaders in life sciences.
We are Industry Veterans
Capturing evolving healthcare trends and emerging cutting-edge innovations
We are Preferred Partners
Connecting companies with extensive network and resources globally and in China
Oricell Therapeutics Receives China NMPA IND Clearance for MSLN/Claudin 18.2 Dual CAR-T Therapy for Solid Tumors
...
November 26, 2024
Adcentrx Therapeutics Announces FDA Clearance of Investigational New Drug Application for ADRX-0405, a Potential First-in-Class ADC Targeting STEAP1 for the Treatment of Advanced Solid Tumors
...
November 26, 2024
Avenzo Therapeutics Announces Appointment of Patrick Machado, J.D. to Board of Directors as Independent Director
...
November 20, 2024
All news